At the news
? NEUTRALIMPACT 3/10 CLUSTER filed Aug 25, 2026 at 16:06 ET
Two insiders at Revolution Medicines, General Counsel Jeff Cislini and Director Mark Goldsmith, sold a combined ~$22.5M in open-market sales on August 21, 2026, following option exercises. The total open-market sales of ~$22.5M represent approximately 0.05% of RVMD's $45.3B market cap, which is below the 0.1% threshold for materiality. While the cluster timing is notable (same-day sales by both insiders), the dollar amount relative to market cap is trivial, and the sales are clearly tied to option exercises (liquidity-driven, not informational).
- Two insiders sold shares on August 21, 2026: General Counsel Jeff Cislini and Director Mark Goldsmith
- Total open-market sales: ~$22.5M (Cislini: ~$11.9M, Goldsmith: ~$10.5M)
- All sales followed option exercises, Cislini exercised options at $0 and $18.56-$21.61 strike, Goldsmith exercised options at $0 strike
- Total sales represent ~0.05% of RVMD's $45.3B market cap, below the 0.1% materiality threshold
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access